CH657047A5 - Composition sous forme de shampooing a base d'un compose d'anthraline. - Google Patents
Composition sous forme de shampooing a base d'un compose d'anthraline. Download PDFInfo
- Publication number
- CH657047A5 CH657047A5 CH6184/82A CH618482A CH657047A5 CH 657047 A5 CH657047 A5 CH 657047A5 CH 6184/82 A CH6184/82 A CH 6184/82A CH 618482 A CH618482 A CH 618482A CH 657047 A5 CH657047 A5 CH 657047A5
- Authority
- CH
- Switzerland
- Prior art keywords
- anthralin
- compound
- composition according
- fatty acid
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 48
- -1 ANTHRALINE COMPOUND Chemical class 0.000 title claims description 18
- 239000002453 shampoo Substances 0.000 title claims description 16
- 229960002311 dithranol Drugs 0.000 claims description 26
- 239000002736 nonionic surfactant Substances 0.000 claims description 14
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 13
- 229930195729 fatty acid Natural products 0.000 claims description 13
- 239000000194 fatty acid Substances 0.000 claims description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 238000011282 treatment Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000003945 anionic surfactant Substances 0.000 claims description 10
- 125000000129 anionic group Chemical group 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 210000004761 scalp Anatomy 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- 201000004681 Psoriasis Diseases 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- NUZWLKWWNNJHPT-UHFFFAOYSA-N anthralin Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 5
- 239000006185 dispersion Substances 0.000 claims description 5
- 229940078545 isocetyl stearate Drugs 0.000 claims description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 5
- VNLRTFSQCPNNIM-UHFFFAOYSA-N octadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC VNLRTFSQCPNNIM-UHFFFAOYSA-N 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 claims description 2
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 claims description 2
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 claims description 2
- AMEMLELAMQEAIA-UHFFFAOYSA-N 6-(tert-butyl)thieno[3,2-d]pyrimidin-4(3H)-one Chemical compound N1C=NC(=O)C2=C1C=C(C(C)(C)C)S2 AMEMLELAMQEAIA-UHFFFAOYSA-N 0.000 claims description 2
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical group CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000005907 alkyl ester group Chemical group 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 229940033357 isopropyl laurate Drugs 0.000 claims description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 2
- 229940089456 isopropyl stearate Drugs 0.000 claims description 2
- 229940105132 myristate Drugs 0.000 claims description 2
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 150000003568 thioethers Chemical class 0.000 claims description 2
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 claims 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims 1
- 239000004711 α-olefin Substances 0.000 claims 1
- MMKRHZKQPFCLLS-UHFFFAOYSA-N ethyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OCC MMKRHZKQPFCLLS-UHFFFAOYSA-N 0.000 description 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Natural products O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8119952A FR2515036B1 (fr) | 1981-10-23 | 1981-10-23 | Composition stable a l'oxydation d'anthraline ou de l'un de ses derives et son utilisation dans le traitement des maladies de la peau |
| FR8205864A FR2524313B2 (fr) | 1982-04-05 | 1982-04-05 | Composition stable a l'oxydation sous forme d'une dispersion ou d'une suspension d'anthraline ou de l'un de ses derives dans un alkyl-ester d'acide gras et son utilisation dans le traitement des maladies de la peau, des ongles et du cuir chevelu |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH657047A5 true CH657047A5 (fr) | 1986-08-15 |
Family
ID=26222595
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH6184/82A CH657047A5 (fr) | 1981-10-23 | 1982-10-22 | Composition sous forme de shampooing a base d'un compose d'anthraline. |
| CH6182/82A CH655004A5 (fr) | 1981-10-23 | 1982-10-22 | Composition anhydre, stable a l'oxydation, d'un compose d'anthraline dans un alkyl-ester d'acide gras en vue du traitement des maladies de la peau. |
| CH6183/82A CH655245A5 (fr) | 1981-10-23 | 1982-10-22 | Composition anhydre, stable a l'oxydation, a base d'un compose d'anthraline dans un support constitue d'un alkyl-ester d'acide gras et d'un agent epaississant. |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH6182/82A CH655004A5 (fr) | 1981-10-23 | 1982-10-22 | Composition anhydre, stable a l'oxydation, d'un compose d'anthraline dans un alkyl-ester d'acide gras en vue du traitement des maladies de la peau. |
| CH6183/82A CH655245A5 (fr) | 1981-10-23 | 1982-10-22 | Composition anhydre, stable a l'oxydation, a base d'un compose d'anthraline dans un support constitue d'un alkyl-ester d'acide gras et d'un agent epaississant. |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US4513011A (en:Method) |
| AU (3) | AU551859B2 (en:Method) |
| CA (3) | CA1179270A (en:Method) |
| CH (3) | CH657047A5 (en:Method) |
| DE (3) | DE3239184C2 (en:Method) |
| GB (3) | GB2107587B (en:Method) |
| IT (3) | IT1153295B (en:Method) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2520233A1 (fr) * | 1982-01-28 | 1983-07-29 | Oreal | Composition d'anthraline ou de l'un de ses derives dans un ester aromatique et son utilisation dans le traitement des maladies de la peau |
| NZ208338A (en) * | 1983-06-09 | 1987-11-27 | Bristol Myers Co | Stabilisation of anthralin compositions by uncorporation of acid-stable anionic surfactant |
| FR2570602B1 (fr) * | 1984-09-21 | 1986-11-28 | Cird | Vehicule pharmaceutique pour substances actives se presentant sous forme d'un gel anhydre |
| US4788061A (en) * | 1985-07-05 | 1988-11-29 | Shore Ronald N | Extended occlusive treatment of skin disorders |
| US5019395A (en) * | 1988-03-08 | 1991-05-28 | Warner-Lambert Company | Compositions with enhanced penetration |
| IE62871B1 (en) * | 1988-03-08 | 1995-03-08 | Warner Lambert Co | Compositions with enhanced penetration |
| LU87201A1 (fr) * | 1988-04-14 | 1989-11-14 | Cird | Complexes a base d'anthraline et d'un sterol,leur procede d'obtention et leur utilisation en therapeutique et cosmetique |
| HU205860B (en) * | 1990-08-24 | 1992-07-28 | Biogal Gyogyszergyar | Process for producing pharmaceutical compositiojns for topical treating psoriasis |
| FR2681247B1 (fr) * | 1991-09-17 | 1993-12-03 | Oreal | Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation. |
| US5314685A (en) * | 1992-05-11 | 1994-05-24 | Agouron Pharmaceuticals, Inc. | Anhydrous formulations for administering lipophilic agents |
| US5248494A (en) * | 1992-06-10 | 1993-09-28 | Young Pharmaceuticals Inc. | Method of reducing anthralin induced inflammation and staining |
| US5476664A (en) * | 1994-04-15 | 1995-12-19 | Leonard Bloom | Treatment of warts using anthralins and occlusion |
| US5776920A (en) * | 1995-08-02 | 1998-07-07 | Quarles; Ruth | Method for treatment of psoriasis |
| US5990100A (en) * | 1998-03-24 | 1999-11-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
| US5886038A (en) * | 1998-03-24 | 1999-03-23 | Panda Pharmaceuticals, L.L.C. | Composition and method for treatment of psoriasis |
| DE19926671A1 (de) * | 1999-06-11 | 2000-12-14 | Wella Ag | Wasserfreie gelförmige Zusammensetzung |
| GB0015617D0 (en) * | 2000-06-26 | 2000-08-16 | Vectura Ltd | Improved preparations for dermal delivery of active substances |
| US6403123B1 (en) * | 2000-09-19 | 2002-06-11 | Eugene J. Van Scott | Method for topical treatment of anthralin-responsive dermatological disorders |
| US20030228374A1 (en) * | 2002-06-07 | 2003-12-11 | Pesacreta Thomas C. | Topical treatment for skin irritation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3881000A (en) * | 1971-09-08 | 1975-04-29 | Mundipharma Ag | Bis-(phosphorylated anthralin) compounds in the treatment of psoriasis and arthritis |
| GB1404583A (en) * | 1971-10-08 | 1975-09-03 | Vymatt Sa | Urea compositions and methods of preparation thereof |
| GB1504007A (en) * | 1976-06-28 | 1978-03-15 | Dermal Lab Ltd | Compositions containing dithranol |
| GB1574090A (en) * | 1977-07-06 | 1980-09-03 | Drythanol Ltd | Dithranol composition for the treatment of psoriasis |
| DD139793A1 (de) * | 1978-11-06 | 1980-01-23 | Waltraud Braun | Mittel gegen psoriasis |
| US4316902A (en) * | 1979-09-21 | 1982-02-23 | Yu Ruey J | Therapeutic compositions and vehicles for topical pharmaceuticals |
| US4287214A (en) * | 1979-09-24 | 1981-09-01 | Scott Eugene J Van | Dithranol compositions stabilized with alpha hydroxyacids |
| US4299826A (en) * | 1979-10-12 | 1981-11-10 | The Procter & Gamble Company | Anti-acne composition |
| FR2492373A1 (fr) * | 1980-10-21 | 1982-04-23 | Cird | Adducts de dihydroxy-1,8 anthrone-9 et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
| FR2492372A1 (fr) * | 1980-10-21 | 1982-04-23 | Cird | Dihydroxy-1,8 anthrones-9 substituees en position 10 et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
| US4367224A (en) * | 1981-05-13 | 1983-01-04 | Scott Eugene J Van | Stable dithranol compositions in anhydrous vehicles |
-
1982
- 1982-10-22 IT IT23893/82A patent/IT1153295B/it active
- 1982-10-22 IT IT23894/82A patent/IT1153296B/it active
- 1982-10-22 US US06/436,046 patent/US4513011A/en not_active Expired - Lifetime
- 1982-10-22 US US06/435,983 patent/US4495203A/en not_active Expired - Lifetime
- 1982-10-22 GB GB08230270A patent/GB2107587B/en not_active Expired
- 1982-10-22 IT IT23892/82A patent/IT1153294B/it active
- 1982-10-22 CA CA000413974A patent/CA1179270A/fr not_active Expired
- 1982-10-22 CA CA000413984A patent/CA1174171A/fr not_active Expired
- 1982-10-22 GB GB08230272A patent/GB2107589B/en not_active Expired
- 1982-10-22 DE DE3239184A patent/DE3239184C2/de not_active Expired - Lifetime
- 1982-10-22 CH CH6184/82A patent/CH657047A5/fr not_active IP Right Cessation
- 1982-10-22 CH CH6182/82A patent/CH655004A5/fr not_active IP Right Cessation
- 1982-10-22 DE DE19823239181 patent/DE3239181A1/de active Granted
- 1982-10-22 CA CA000413996A patent/CA1179271A/fr not_active Expired
- 1982-10-22 GB GB08230271A patent/GB2107588B/en not_active Expired
- 1982-10-22 DE DE19823239183 patent/DE3239183A1/de active Granted
- 1982-10-22 CH CH6183/82A patent/CH655245A5/fr not_active IP Right Cessation
- 1982-10-25 AU AU89734/82A patent/AU551859B2/en not_active Expired
- 1982-10-25 AU AU89735/82A patent/AU551900B2/en not_active Expired
- 1982-10-25 AU AU89736/82A patent/AU551719B2/en not_active Expired
-
1988
- 1988-03-31 US US07/175,602 patent/US4892888A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IT8223892A0 (it) | 1982-10-22 |
| AU8973482A (en) | 1983-04-28 |
| GB2107588B (en) | 1985-04-11 |
| AU8973582A (en) | 1983-04-28 |
| AU551859B2 (en) | 1986-05-15 |
| GB2107589B (en) | 1985-04-11 |
| IT1153296B (it) | 1987-01-14 |
| CH655004A5 (fr) | 1986-03-27 |
| GB2107589A (en) | 1983-05-05 |
| CA1174171A (fr) | 1984-09-11 |
| DE3239184A1 (de) | 1983-05-26 |
| AU551900B2 (en) | 1986-05-15 |
| AU8973682A (en) | 1983-04-28 |
| DE3239183A1 (de) | 1983-05-05 |
| GB2107587B (en) | 1985-04-11 |
| CH655245A5 (fr) | 1986-04-15 |
| GB2107588A (en) | 1983-05-05 |
| DE3239181C2 (en:Method) | 1990-12-20 |
| GB2107587A (en) | 1983-05-05 |
| CA1179270A (fr) | 1984-12-11 |
| US4513011A (en) | 1985-04-23 |
| IT8223894A0 (it) | 1982-10-22 |
| DE3239181A1 (de) | 1983-05-05 |
| AU551719B2 (en) | 1986-05-08 |
| IT1153295B (it) | 1987-01-14 |
| IT1153294B (it) | 1987-01-14 |
| CA1179271A (fr) | 1984-12-11 |
| DE3239183C2 (en:Method) | 1990-12-13 |
| DE3239184C2 (de) | 1994-05-11 |
| US4892888A (en) | 1990-01-09 |
| US4495203A (en) | 1985-01-22 |
| IT8223893A0 (it) | 1982-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH657047A5 (fr) | Composition sous forme de shampooing a base d'un compose d'anthraline. | |
| CA1289888C (fr) | Composition therapeutique ou cosmetique sous forme d'une solution liquide deperoxide d'hydrogene essentiellement anhydre | |
| CA1166578A (fr) | Composition cosmetique capillaire, contenant un extrait de salsepareille | |
| EP0141732B1 (fr) | Composition cosmetique de nettoyage en particulier pour le démaquillage des yeux | |
| US5886031A (en) | Hair-care cosmetic compositions having dandruff formation-suppressing effect | |
| EP0767781B1 (fr) | Nouveaux derives d'ammoniums quaternaires, leur procede de preparation et leur utilisation comme agents de surface | |
| EP0717981B1 (fr) | Composition cosmétique, dermatologique ou pharmaceutique stable contenant du disulfure de sélénium et au moins un sel de zinc | |
| CA1186233A (fr) | Produit nettoyant des cheveux et de la peau a base d'acylisethionates et de polymeres cationiques | |
| CA1275626C (fr) | Utilisation de poudre de graines de lupin doux dans la realisation de compositions cosmetiques ou dermopharmaceutiques, et compositions obentues | |
| WO1997031615A1 (fr) | Dispositif pressurise transparent a composition moussante comprenant des tensioactifs non-ioniques et amphoteres | |
| FR2601587A1 (fr) | Procede de teinture des cheveux avec des colorants hydroxyquinoniques et des sels metalliques | |
| CH635510A5 (fr) | Composition cosmetique pour le demaquillage des yeux. | |
| CH633179A5 (fr) | Composition pour le demaquillage des yeux. | |
| EP0133129B1 (fr) | Procédé et compositions pour la coloration des phanères | |
| FR2837697A1 (fr) | Composition cosmetique moussante ; utilisations pour le nettoyage ou le demaquillage | |
| EP0701433B1 (fr) | Compositions cosmetiques contenant au moins un tensio-actif anionique du type alkylgalactoside uronate et au moins un tensio-actif du type alkylpolyglycoside et/ou polyglycerole | |
| FR2693206A1 (fr) | Utilisation dans des solutions d'agents tensioactifs de carbamates d'aminopolyols en tant qu'épaississants et compositions les contenant. | |
| CA1341268C (fr) | Composition pour induire et stimuler la croissance des cheveux et/ou freiner leur chute | |
| CA1083482A (fr) | Lotion demaquillante pour les yeux | |
| FR2694191A1 (fr) | Compositions cosmétiques ou dermatologiques, en particulier des shampooings, diluables à l'eau sans perte de viscosité après dilution. | |
| CA1341187C (fr) | Composition pour induire et stimuler la croissance des cheveux et/ou freiner leur chute, a base d'un tensio-actif non ionique et d'un derive de pyrimidine | |
| WO1998011868A1 (fr) | Dispositif pressurise a composition moussante comprenant des tensioactifs non-ioniques et anioniques | |
| FR2515036A1 (fr) | Composition stable a l'oxydation d'anthraline ou de l'un de ses derives et son utilisation dans le traitement des maladies de la peau | |
| FR2524313A2 (fr) | Composition stable a l'oxydation sous forme d'une dispersion ou d'une suspension d'anthraline ou de l'un de ses derives dans un alkyl-ester d'acide gras et son utilisation dans le traitement des maladies de la peau, des ongles et du cuir chevelu | |
| FR2727979A1 (fr) | Compositions a base d'un systeme abrasif et d'un systeme tensio-actif |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |